Skip to main navigation Skip to search Skip to main content

Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: An experience at a tertiary-care center

  • Shutaro Murakami
  • , Akane Takamatsu
  • , Manabu Akazawa
  • , Takao Goto
  • , Toshiki Miwa
  • , Yoshiyasu Terayama
  • , Hitoshi Honda

Research output: Contribution to journalArticlepeer-review

Abstract

Antimicrobial use during the coronavirus disease 2019 (COVID-19) pandemic at a tertiary-care center was analyzed using interrupted time-series analysis. Among intravenous antimicrobials, the use of azithromycin and third-generation cephalosporins significantly decreased during the current pandemic. Similarly, the use of oral antimicrobials, including azithromycin and fluoroquinolones, also decreased.

Original languageEnglish
Article numbere53
JournalAntimicrobial Stewardship and Healthcare Epidemiology
Volume2
Issue number1
DOIs
Publication statusPublished - 05-04-2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: An experience at a tertiary-care center'. Together they form a unique fingerprint.

Cite this